An FDA Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition
Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, be added to a list that will allow certain specialty pharmacies to dispense them. Currently, those peptides—and the other five being considered—are in a legal gray area. Here’s what to know.What are peptides?Peptides are short chains of amino acids, which are the building blocks of proteins.
- ▪Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, be added to a list that will allow certain specialty pharmacies to dispense th
- ▪Currently, those peptides—and the other five being considered—are in a legal gray area.
- ▪Here’s what to know.What are peptides?Peptides are short chains of amino acids, which are the building blocks of proteins.
TIME — Top files mainly under news. We currently carry 213 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | TIME — Top |
| Canonical URL | https://time.com/article/2026/07/23/fda-committee-peptides/ |
| Publication time | Thu, 23 Jul 2026 20:19:08 +0000 |
| Retrieval time | 2026-07-23T20:25:30.857Z |
| Last seen | 2026-07-23T20:25:30.857Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | EBdZ3EcBcn5p |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
In a highly unusual move, a U.S. Food and Drug Administration (FDA) committee voted against FDA staff’s own advice in a meeting on July 23, recommending that two peptides, called BP-157 and KPV, be added to a list that will allow certain specialty pharmacies to dispense them. Currently, those peptides—and the other five being considered—are in a legal gray area. Here’s what to know.What are peptides?Peptides are short chains of amino acids, which are the building blocks of proteins. Peptide concoctions have grown in popularity over the past several years as injectable substances that proponents claim improve energy, sleep, sex drive, and more. U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has supported reclassifying peptides to improve people’s access to them.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at TIME — Top.
Discussion
0 commentsMore from TIME — Top
